These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32196884)

  • 1. Transforming growth factor beta 1 levels in the blood of pediatric liver recipients: Clinical and biochemical correlations.
    Kurabekova R; Tsirulnikova O; Pashkova I; Gichkun O; Mozheyko N; Gautier S; Shevchenko O
    Pediatr Transplant; 2020 May; 24(3):e13693. PubMed ID: 32196884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hematopoietic stem cell number in the peripheral blood of pediatric recipients correlates with the outcome after living donor liver transplantation.
    Gautier SV; Shevchenko OP; Tsirulnikova OM; Kurabekova RM; Lugovskaya SA; Naumova EV; Tsirulnikova IE; Dolgov VV
    Pediatr Transplant; 2015 Aug; 19(5):531-7. PubMed ID: 25951239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Causes and Outcomes of Early Relaparotomy Following Pediatric Living Donor Liver Transplantation.
    Okada N; Sanada Y; Onishi Y; Urahashi T; Ihara Y; Yamada N; Hirata Y; Katano T; Imai T; Ushijima K; Ogaki K; Otomo S; Mizuta K
    Liver Transpl; 2019 Jul; 25(7):1066-1073. PubMed ID: 30865366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The travails of setting up a living donor liver transplant program: Experience from Pakistan and lessons learned.
    Dar FS; Bhatti AB; Dogar AW; Zia H; Amin S; Rana A; Nazer R; Khan NA; Khan EU; Rajput MZ; Salih M; Shah NH
    Liver Transpl; 2015 Jul; 21(7):982-90. PubMed ID: 25891412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens.
    Citterio F; Pozzetto U; Romagnoli J; Tondolo E; Silvestri P; Nanni G; Castagneto M
    Transplant Proc; 2004 Apr; 36(3):698-9. PubMed ID: 15110635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living donor liver transplantation during the first 3 months of life.
    Kasahara M; Sakamoto S; Sasaki K; Uchida H; Kitajima T; Shigeta T; Narumoto S; Hirata Y; Fukuda A
    Liver Transpl; 2017 Aug; 23(8):1051-1057. PubMed ID: 28220684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living donor liver transplantation for post-Kasai biliary atresia: Analysis of pretransplant predictors of outcomes in infants.
    Kitajima T; Sakamoto S; Sasaki K; Uchida H; Narumoto S; Fukuda A; Teramukai S; Uemoto S; Kasahara M
    Liver Transpl; 2017 Sep; 23(9):1199-1209. PubMed ID: 28590589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and Safety of Split-Liver Transplantation in a Nascent Framework of Deceased Donation.
    Cherukuru R; Reddy MS; Shanmugam NP; Rajalingam R; Kota V; Gunasekaran V; Narasimhan G; Kaliamoorthy I; Rela M
    Liver Transpl; 2019 Mar; 25(3):450-458. PubMed ID: 30586233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor and transforming growth factor beta1 contribute to regeneration of small-for-size liver graft immediately after transplantation.
    Ninomiya M; Harada N; Shiotani S; Hiroshige S; Minagawa R; Soejima Y; Suehiro T; Nishizaki T; Shimada M; Sugimachi K
    Transpl Int; 2003 Nov; 16(11):814-9. PubMed ID: 12879228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Proper Graft Selection in Adult Living-Donor Liver Transplant Recipients with Preoperative Deteriorated Condition.
    Iida T; Masuda K; Matsuyama T; Harada S; Nakamura T; Koshino K; Suzuki T; Nobori S; Ushogome H; Ito T; Sakamoto S; Uryuhara K; Okajima H; Kaihara S; Uemoto S; Yoshimura N
    Ann Transplant; 2017 Sep; 22():541-549. PubMed ID: 28883387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone/insulin-like growth factor 1 dynamics in adult living donor liver transplantation.
    Jara M; Schulz A; Malinowski M; Puhl G; Lock JF; Seehofer D; Neuhaus P; Stockmann M
    Liver Transpl; 2014 Sep; 20(9):1118-26. PubMed ID: 24889799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of gross post-transplant outcomes based on the intra-operative decline in C-reactive protein in living donor liver transplantation.
    Chung HS; Kim ES; Park JH; Park CS
    Transplant Proc; 2015 Mar; 47(2):431-7. PubMed ID: 25769586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE; Perkins JD; Reyes JD; Montenovo MI
    Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric patients receiving ABO-incompatible living related liver transplantation exhibit higher serum transforming growth factor-β1, interferon-γ and interleukin-2 levels.
    Hussein MH; Hashimoto T; AbdEl-Hamid Daoud G; Kato T; Hibi M; Tomishige H; Hara F; Suzuki T; Nakajima Y; Goto T; Ito T; Kato I; Sugioka A; Togari H
    Pediatr Surg Int; 2011 Mar; 27(3):263-8. PubMed ID: 21046118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of early recovery of graft function after living donor liver transplantation in children.
    Tan B; Yang C; Hu J; Xing H; Zhang M
    Sci Rep; 2024 Apr; 14(1):9472. PubMed ID: 38658800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children.
    Przybyszewski EM; Verna EC; Lobritto SJ; Martinez M; Vittorio JM; Fox AN; Samstein B; Kato T; Griesemer AD; Emond JC
    Transplantation; 2018 Jun; 102(6):953-960. PubMed ID: 29369249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
    Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease.
    Liem LM; Fibbe WE; van Houwelingen HC; Goulmy E
    Transplantation; 1999 Jan; 67(1):59-65. PubMed ID: 9921796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor hypernatremia before procurement and early outcomes following pediatric liver transplantation.
    Kaseje N; McLin V; Toso C; Poncet A; Wildhaber BE
    Liver Transpl; 2015 Aug; 21(8):1076-81. PubMed ID: 25902852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.